- Darling Dendreon Takes Hits As Speculators Continue To Bet On Immunotherapy Plays
- Frost Swoops In To Buy More Cheap Prolor Biotech Shares
- Adventrx CEO Attempting To Prime His Firm For A Comeback
- Incyte's Potential Blockbuster Pipeline Asset Makes It An Attractive Takeover Target
- Pozen Shares On The Rebound Since European Migraine Licensing Deal
M. E. Garza
M. E. Garza
Send Message
M. E. Garza
Stop FollowingM. E. Garza
ABOUT
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began publishing in 2008, Garza has built a reputation as a writer and reporter who can move markets. His track record for accurately reporting rumors and alerting readers about developments in the biotech/healthcare sector is unmatched during that time.
SNAPSHOT
- Description: Newsletter author. Trading frequency: Daily
- Interests: Stocks - long, Tech stocks
COMPANY
BioMedReports.Com
BioMedReports.com, designed by and for investors and traders, is a full news portal offering unbiased bio stock reporting and analysis about emerging biotech companies, offering FDA and clinical trial calendars and valuable industry and stock market information.
BLOG
Daily Info Feeds and Updates
I don't keep a blog, but I often update our readers via twitter and our premium subscribers can often find my reporter's notes on stories and stocks that I will be covering in upcoming days.
For more information on getting that information go here:
http://biomedreports.com/only-premium-access.html
For more information on getting that information go here:
http://biomedreports.com/only-premium-access.html
Book
Currently, there are no book details for M. E. Garza.
LATEST STOCKTALK
more »
Hearing some interesting developments on the horizon for $NWBO. Did an article on them yesterday. Looks promising. http://bit.ly/NWBOnews
Jul 12, 2011
Latest Comments
more »
- Nice call! on 2 Big Board Biotech Breakout Candidates With Re...
- Congratulations to all the ... on The Best SA Articles Of All Time, As Chosen By ...
- Yeah. These guys have no cl... on Vringo May Be Getting Ready For The Next Leg Up
- Good stuff. Thanks for post... on Mid Cap Biotech Stocks Being Accumulated By The...
- Illumina (ILMN) must be sit... on Wall Street Breakfast: Must-Know News
Latest comments on M. E.'s Articles
more »
- indiansfan407 on Darling Dendreon Takes Hits As Speculators Cont...
- Scott Matusow on Darling Dendreon Takes Hits As Speculators Cont...
- thresherfailed on Adventrx CEO Attempting To Prime His Firm For A...
- Theodore Cohen on Darling Dendreon Takes Hits As Speculators Cont...
- Theodore Cohen on Darling Dendreon Takes Hits As Speculators Cont...
LATEST ARTICLES & INSTAPOSTS
more »


